Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Angelica S.I. Loskog"'
The use of multiplex platforms for absolute and relative protein quantification of clinical material
Autor:
Lisa Christiansson, Satu Mustjoki, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S.I. Loskog, Sara M. Mangsbo
Publikováno v:
EuPA Open Proteomics, Vol 3, Iss C, Pp 37-47 (2014)
When introducing multiplex platforms to measure protein content in precious clinical material there is an increased risk of cross reactivity, loss of sensitivity as well as accuracy. In this paper, four multiplex platforms and one singleplex platform
Externí odkaz:
https://doaj.org/article/c6349e31a24c453f9d90cf061cf9ffb4
Autor:
Thomas H. Tötterman, Truls Gårdmark, Alkwin Wanders, Moa Fransson, Sara M. Mangsbo, Camilla A. Lindqvist, Angelica S.I. Loskog, Per-Uno Malmström
Purpose: Immunotherapy with Bacillus Calmette-Guerin (BCG) instillation is recommended for high-risk, non–muscle invasive bladder cancer. Bacillus Calmette-Guerin is not effective in advanced tumors, and better alternatives are warranted. Immunosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a410d608af9bc0894df747d2606f639
https://doi.org/10.1158/1078-0432.c.6519041.v1
https://doi.org/10.1158/1078-0432.c.6519041.v1
Supplementary Data from AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
Autor:
Thomas H. Tötterman, Truls Gårdmark, Alkwin Wanders, Moa Fransson, Sara M. Mangsbo, Camilla A. Lindqvist, Angelica S.I. Loskog, Per-Uno Malmström
Supplementary Data from AdCD40L Immunogene Therapy for Bladder Carcinoma—The First Phase I/IIa Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8342b73abd77b116009604c71a82a70
https://doi.org/10.1158/1078-0432.22442252.v1
https://doi.org/10.1158/1078-0432.22442252.v1
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 85K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aef0e78ec35129f58805f4d42adb7dc
https://doi.org/10.1158/0008-5472.22395554
https://doi.org/10.1158/0008-5472.22395554
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 128K, T-cell analyses in C57Bl/6 mice bearing B16-Ova tumors C57Bl/6 mice bearing B16-Ova tumors were injected intratumorally. Lymph nodes, spleens and tumors were collected 8 days after first virus injection, homogenized and cultured for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac503bbe03918ddb456fd777c8c6180e
https://doi.org/10.1158/0008-5472.22395557
https://doi.org/10.1158/0008-5472.22395557
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 91K, Nude mice bearing MB49 tumors were injected with Ad5/3-CMV-mCD40L, Ad5/3-Luc1 or PBS (Mock) on days 0,2 and 4. Eight days after first virus injection mice were killed and spleens and tumors were collected, smashed and cultured for 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12039057d9e7186a6088131489b12079
https://doi.org/10.1158/0008-5472.22395563.v1
https://doi.org/10.1158/0008-5472.22395563.v1
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 2.2MB, (A) Cell monolayers were infected with 100 viral paticles /cell (VP/cell) and 24 hours later cells were analyzed by flow-cytometry measuring Annexin-V expression. Results are presented as percentage of positive cells relative to Moc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2080e12b4cc2bf5f40a720980efd53
https://doi.org/10.1158/0008-5472.22395569.v1
https://doi.org/10.1158/0008-5472.22395569.v1
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 75K, (A) MB49 cells were infected with 100 viral particles/cell with Ad5/3-CMV-mCD40L and Ad5/3-Luc1 and Annexin-V was assessed 24 hours post-infection by flow cytometry. (B) Replication of Ad5/3-CMV-mCD40L and Ad5/3-Luc1 over time in MB49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56293b03732b7ba4ff59f7d1801544d5
https://doi.org/10.1158/0008-5472.22395566
https://doi.org/10.1158/0008-5472.22395566
Autor:
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu
PDF file - 881K, (A) Oncolytic potency of Ad5/3-hTERT-E1A-hCD40L and (B) Ad5/3-hTERT-E1A on EJ (CD40+) and A549 (CD40-). Cell lines were infected with Ad5/3Luc1, Ad5/3-hTERT-E1A, Ad5/3-hTERT-E1A-hCD40L and Ad5/3-CMV-hCD40L and cell viability was meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a354c85f44eba9b8b9df19283bb3b8bd
https://doi.org/10.1158/0008-5472.22395572.v1
https://doi.org/10.1158/0008-5472.22395572.v1